New hope for young patients battling aggressive cancers
Disease control
Recruiting now
This study is testing a new drug called PEEL-224 combined with two existing cancer drugs to see if it can help control aggressive sarcomas that have returned or stopped responding to standard treatments. It will involve about 63 adolescents and young adults (ages 12-49) with spec…
Phase: PHASE1, PHASE2 • Sponsor: David S Shulman, MD • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC